Pfizer’s Investor Call Reveals The Company’s Plan To Capitalize On Its Failed COVID Drugs For Years

In a recent investor call with Pfizer’s leadership and key financial backers, CEO Albert Bourla made it clear that the company has plans to capitalize on its failed COVID vaccines and antiviral drugs for years.  “Hopefully, we could be giving it annually and maybe for some groups that are high-risk more often,” Bourla told investors earlier this … Continue reading Pfizer’s Investor Call Reveals The Company’s Plan To Capitalize On Its Failed COVID Drugs For Years